Imcyse raises a total of € 35 million in equity and grants and will use proceeds to facilitate clinical development of it’s technology in type 1 diabetes, multiple sclerosis and other indications
Liège [...]
UTRECHT, The Netherlands, May 30, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative [...]
Breda, the Netherlands / Ghent, Belgium, May 28, 2019 – argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatme [...]
Expands pipeline with ARGX-117 and ARGX-118; two new pipeline candidates from its Innovative Access Program addressing first-in-class targets
Highlights formation of two global therapeutic franchises in neur [...]
Amsterdam, The Netherlands, May 22, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, today announced that it has submitte [...]
Oversubscribed round led by LSP will fund accelerated product development and commercial operations in the U.S.
Paris, May 16, 2019 — DNA Script today announced an oversubscribed Series B fundraising of $ [...]
Breda, the Netherlands / Ghent, Belgium, May 9, 2019 - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment [...]
Basel, Switzerland, May 7, 2019 – LSP is pleased to announce that Okairos has been recognised as one of the winners of the Swiss Biotech Success Stories Awards 2018/ 2019.
Okairos (now GlaxoSmithKline) has dev [...]
Multiplex Test Panel for binx io® Point-of-Care Platform
Positioned to Radically Reduce Time to Treatment, Expand Access to Care
May 1, 2019 (BOSTON, MA) – Binx Health, the pioneer in anywhere care tod [...]
Imcyse raises a total of € 35 million in equity and grants and will use proceeds to facilitate clinical development of it’s technology in type 1 diabetes, multiple sclerosis and other indications
Liège [...]
UTRECHT, The Netherlands, May 30, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative [...]
Breda, the Netherlands / Ghent, Belgium, May 28, 2019 – argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatme [...]
Expands pipeline with ARGX-117 and ARGX-118; two new pipeline candidates from its Innovative Access Program addressing first-in-class targets
Highlights formation of two global therapeutic franchises in neur [...]
Amsterdam, The Netherlands, May 22, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, today announced that it has submitte [...]
Oversubscribed round led by LSP will fund accelerated product development and commercial operations in the U.S.
Paris, May 16, 2019 — DNA Script today announced an oversubscribed Series B fundraising of $ [...]
Breda, the Netherlands / Ghent, Belgium, May 9, 2019 - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment [...]
Basel, Switzerland, May 7, 2019 – LSP is pleased to announce that Okairos has been recognised as one of the winners of the Swiss Biotech Success Stories Awards 2018/ 2019.
Okairos (now GlaxoSmithKline) has dev [...]
Multiplex Test Panel for binx io® Point-of-Care Platform
Positioned to Radically Reduce Time to Treatment, Expand Access to Care
May 1, 2019 (BOSTON, MA) – Binx Health, the pioneer in anywhere care tod [...]
Follow us
